ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Randomized, Single-Blind, Phase I Trial (INVICTAN®-1) Assessing the Pharmacokinetic Bioequivalence and Safety of BI 695502, a Bevacizumab Biosimilar Candidate, in Healthy Subjects
Mapping Intimacies
◽
10.26226/morressier.57d6b2b8d462b8028d88ea33
◽
2016
◽
Author(s):
Mario Altendorfer
Keyword(s):
Phase I
◽
Healthy Subjects
◽
Phase I Trial
◽
Single Blind
Download Full-text
Related Documents
Cited By
References
A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2017.1347635
◽
2017
◽
Vol 26
(8)
◽
pp. 889-896
◽
Cited By ~ 9
Author(s):
Willem Hettema
◽
Christopher Wynne
◽
Benjamin Lang
◽
Mario Altendorfer
◽
Niklas Czeloth
◽
...
Keyword(s):
Phase I
◽
Healthy Subjects
◽
Phase I Trial
◽
Single Blind
Download Full-text
BCX7353, a Potent Inhibitor of Plasma Kallikrein, Shows Sustained Maximal Enzyme Inhibition When Dosed Orally Once Daily: Results from a Phase I Trial in Healthy Subjects
Journal of Allergy and Clinical Immunology
◽
10.1016/j.jaci.2015.12.1243
◽
2016
◽
Vol 137
(2)
◽
pp. AB401
◽
Cited By ~ 3
Author(s):
Melanie Cornpropst
◽
Sylvia Dobo
◽
Jo Collier
◽
Angela Rose
◽
Ramanda Wilson
◽
...
Keyword(s):
Phase I
◽
Enzyme Inhibition
◽
Healthy Subjects
◽
Phase I Trial
◽
Potent Inhibitor
◽
Plasma Kallikrein
◽
Once Daily
Download Full-text
Safety, Tolerability (S&T) and Pharmacokinetics (PK) of Single and Repeat Inhaled Doses of Phosphoinositide-3-Kinase Delta Inhibitor (PI3Kδ) GSK2269557, Delivered via the ELLIPTATM Device to Healthy Subjects in a Phase I Trial, Including Charcoal Block
10.1183/1393003.congress-2017.pa520
◽
2017
◽
Author(s):
Robert Wilson
◽
Emily Jarvis
◽
Mickael Montembault
◽
Nicole Hamblin
◽
Edith M. Hessel
◽
...
Keyword(s):
Phase I
◽
Healthy Subjects
◽
Phase I Trial
◽
Phosphoinositide 3 Kinase
Download Full-text
Study on Pharmacokinetic Interactions Between HS-10234 and Emtricitabine in Healthy Subjects: An Open-Label, Two-Sequence, Self-Controlled Phase I Trial
Infectious Diseases and Therapy
◽
10.1007/s40121-021-00555-y
◽
2021
◽
Author(s):
Yeping Luo
◽
Wenjing Chen
◽
Guoping Yang
◽
Chan Zou
◽
Jie Huang
◽
...
Keyword(s):
Phase I
◽
Healthy Subjects
◽
Phase I Trial
◽
Open Label
◽
Pharmacokinetic Interactions
Download Full-text
Effect of gender and age on the relative bioavailability of doravirine: results of a Phase I trial in healthy subjects
Antiviral Therapy
◽
10.3851/imp3142
◽
2017
◽
Vol 22
(4)
◽
pp. 337-344
◽
Cited By ~ 16
Author(s):
Martin O Behm
◽
Ka L Yee
◽
Li Fan
◽
Paul Fackler
Keyword(s):
Phase I
◽
Healthy Subjects
◽
Phase I Trial
◽
Relative Bioavailability
◽
Gender And Age
Download Full-text
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects
CNS Drugs
◽
10.1007/s40263-020-00738-0
◽
2020
◽
Vol 34
(8)
◽
pp. 853-865
◽
Cited By ~ 1
Author(s):
Michael J. Fossler
◽
Virginia Schmith
◽
Stephen A. Greene
◽
Lauren Lohmer
◽
Michael S. Kramer
◽
...
Keyword(s):
Phase I
◽
G Protein
◽
Healthy Subjects
◽
Receptor Agonist
◽
Dose Study
◽
Delta Receptor
◽
Single Blind
◽
Single Ascending Dose Study
Download Full-text
Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial
PLoS ONE
◽
10.1371/journal.pone.0101591
◽
2014
◽
Vol 9
(7)
◽
pp. e101591
◽
Cited By ~ 49
Author(s):
Emma-Jo Hayton
◽
Annie Rose
◽
Umar Ibrahimsa
◽
Mariarosaria Del Sorbo
◽
Stefania Capone
◽
...
Keyword(s):
Human Immunodeficiency Virus
◽
Phase I
◽
Vaccinia Virus
◽
Plasmid Dna
◽
Phase I Trial
◽
Modified Vaccinia Virus Ankara
◽
Immunodeficiency Virus
◽
Simian Adenovirus
◽
Single Blind
Download Full-text
604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer
The Journal of Urology
◽
10.1016/s0022-5347(18)30844-9
◽
2007
◽
Vol 177
(4S)
◽
pp. 202-202
Author(s):
Hirotsugu Uemura
◽
Motoyoshi Tanaka
◽
Shigeya Uejima
◽
Takafumi Minami
◽
Kiyohide Fujimoto
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Phase I Trial
◽
Hormone Refractory Prostate Cancer
◽
Hormone Refractory
Download Full-text
Phase I Trial and Pharmacokinetics Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas
Yearbook of Oncology
◽
10.1016/s1040-1741(08)70478-0
◽
2007
◽
Vol 2007
◽
pp. 292-293
Author(s):
R.J. Arceci
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Trial
◽
Neurofibromatosis Type
◽
Type I
◽
Neurofibromatosis Type I
◽
Farnesyltransferase Inhibitor
◽
Plexiform Neurofibromas
◽
Pharmacokinetics Study
Download Full-text
The PACOVAR-trial: A multicenter phase I trial of pazopanib (GW786034) and metronomic cyclophosphamide in patients with recurrent platinum-resistant ovarian cancer
Geburtshilfe und Frauenheilkunde
◽
10.1055/s-0036-1592664
◽
2016
◽
Vol 76
(10)
◽
Author(s):
C Mayer
◽
M Schmidt
◽
EM Grischke
◽
G Gebauer
◽
HC Fricke
◽
...
Keyword(s):
Ovarian Cancer
◽
Phase I
◽
Phase I Trial
◽
Multicenter Phase
◽
Platinum Resistant
◽
Metronomic Cyclophosphamide
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close